Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

908 Devices Inc. Stock Research

MASS

6.05USD+0.01(+0.17%)Market Closed
Watchlist

Market Summary

USD6.05+0.01
Market Closed
0.17%

MASS Stock Price

MASS RSI Chart

MASS Valuation

Market Cap

195.6M

Price/Earnings (Trailing)

-5.15

Price/Sales (Trailing)

3.99

EV/EBITDA

-1.8

Price/Free Cashflow

-6.22

MASS Price/Sales (Trailing)

MASS Profitability

Operating Margin

54.71%

Return on Equity

-20.33%

Return on Assets

-16.81%

Free Cashflow Yield

-16.08%

MASS Fundamentals

MASS Revenue

Revenue (TTM)

49.0M

Revenue Y/Y

8.9%

Revenue Q/Q

27.48%

MASS Earnings

Earnings (TTM)

-38.0M

Earnings Y/Y

-15.4%

Earnings Q/Q

25.42%

Price Action

52 Week Range

5.6918.02
(Low)(High)

Last 7 days

-1.1%

Last 30 days

-16.1%

Last 90 days

-10.2%

Trailing 12 Months

-60.1%

MASS Financial Health

Current Ratio

10.07

MASS Investor Care

Shares Dilution (1Y)

2.91%

Diluted EPS (TTM)

-1.19

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for MASS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-06-14
HRUSOVSKY E KEVIN
acquired
-
-
4,771
-
2023-06-14
CRANDELL KEITH
acquired
-
-
4,771
-
2023-06-14
ELOI FENEL M
acquired
-
-
4,771
-
2023-06-14
George Jeffrey P.
acquired
-
-
4,771
-
2023-06-14
Hunt Anthony
acquired
-
-
4,771
-
2023-06-14
Eisenberg Marcia
acquired
-
-
4,771
-
2023-06-14
Spoto Mark
acquired
-
-
4,771
-
2023-06-07
Brown Christopher D.
sold
-44,834
10.03
-4,470
chief product officer
2023-06-07
Eisenberg Marcia
acquired
-
-
681
-
2023-06-05
Knopp Kevin J.
acquired
49,875
1.75
28,500
president and ceo

1–10 of 50

Which funds bought or sold MASS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-20
BARCLAYS PLC
reduced
-59.6
-65,000
31,000
-%
2023-09-12
Farther Finance Advisors, LLC
unchanged
-
-28.00
110
-%
2023-08-22
COMERICA BANK
new
-
-
-
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-11.19
-20,598
50,051
-%
2023-08-21
OSAIC HOLDINGS, INC.
reduced
-60.4
-12,596
5,949
-%
2023-08-16
Nuveen Asset Management, LLC
added
62.14
146,308
646,308
-%
2023-08-15
ALLIANCEBERNSTEIN L.P.
added
10.14
-23,088
166,972
-%
2023-08-15
Sands Capital Ventures, LLC
reduced
-27.32
-1,179,680
1,627,590
0.48%
2023-08-15
GOLDMAN SACHS GROUP INC
added
1,732
2,203,960
2,365,840
-%
2023-08-15
WELLS FARGO & COMPANY/MN
added
95.4
24,148
67,372
-%

1–10 of 48

Latest Funds Activity

Are funds buying MASS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MASS
No. of Funds

Schedule 13G FIlings of 908 Devices

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
alger associates inc
8.8%
2,805,216
SC 13G/A
Feb 14, 2023
eventide asset management, llc
7.0%
2,230,665
SC 13G
Feb 13, 2023
arch venture fund vii, l.p.
18.1%
5,725,045
SC 13G/A
Feb 01, 2023
blackrock inc.
5.6%
1,763,507
SC 13G/A
Jul 08, 2022
blackrock inc.
7.4%
2,318,894
SC 13G
Feb 09, 2022
ark investment management llc
9.66%
2,996,393
SC 13G/A
Feb 08, 2022
arch venture fund vii, l.p.
18.5%
5,725,045
SC 13G/A

Recent SEC filings of 908 Devices

View All Filings
Date Filed Form Type Document
Aug 08, 2023
8-K
Current Report
Aug 08, 2023
10-Q
Quarterly Report

908 Devices News

Nasdaq
Stephens & Co. Reiterates 908 Devices (MASS) Overweight ....
Nasdaq,
5 hours ago
Research & Development World
2023 R&D 100 Award Winners. - Research & Development World
Research & Development World,
34 days ago
Research & Development World
R&D 100 Winners for 2023 are announced - Research ....
Research & Development World,
35 days ago
Cannabis & Tech Today
Nanalyze
Research & Development World
R&D 100 Finalists for 2023 are announced - Research ....
Research & Development World,
42 days ago

Returns for MASS

Cumulative Returns on MASS

Risks for MASS

What is the probability of a big loss on MASS?

97.9%


Probability that 908 Devices stock will be more than 20% underwater in next one year

92.4%


Probability that 908 Devices stock will be more than 30% underwater in next one year.

92.4%


Probability that 908 Devices stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MASS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if 908 Devices was unfortunately bought at previous high price.

Drawdowns

Financials for 908 Devices

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Last 12 Months)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q1
Revenue2.1%49,02148,03346,85251,05047,79844,96942,20632,08225,58528,43626,89428,23630,25816,004
Gross Profit-3.2%25,43826,27826,02329,23526,70924,45423,23316,67813,70215,73314,92316,45917,0168,392
Operating Expenses2.7%66,88665,15661,40557,80753,40350,23445,30239,10532,14624,59420,73819,03118,28819,448
  S&GA Expenses1.1%46,63546,13743,87941,19838,15836,22732,23527,50121,89315,55012,50311,09310,28410,824
  R&D Expenses6.5%20,22518,99317,50016,60915,24514,00713,06711,60410,2539,0448,2357,9378,0048,624
Interest Expenses-2.3%6456601291081061304866909041,111976976974964
Earnings Before Taxes-Infinity%-37,668----32,396---------
Net Income-3.4%-37,965-36,718-33,600-27,238-26,164-25,489-22,169-28,930-25,467-15,948-12,819-3,457-1,742-11,864
Net Income Margin100.0%--0.76*-0.72*-0.53*-0.55*-0.57*-0.53*-0.90*-0.99*-0.53*-0.45*-0.12*-0.06*-0.74*
Free Cashflow100.0%--33,724-22,975-26,521-23,821-21,260-29,819-18,213-6,859-6,1242,3872,387-13,164-13,036
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q4
Assets-3.5%211218243249247251261166166172179
  Current Assets-3.7%181188216224239243253157157163171
    Cash Equivalents-17.5%133161188194213223224139141149159
  Inventory5.7%14.0013.0013.0012.0011.0010.008.008.008.007.005.00
  Net PPE-3.4%3.003.003.003.002.002.002.002.002.001.001.00
  Goodwill-0.4%10.0010.0010.009.00-------
Liabilities-3.8%36.0038.0052.0053.0046.0044.0046.0044.0040.0038.0040.00
  Current Liabilities8.2%20.0019.0019.0019.0015.0014.0015.0013.0011.009.0011.00
    LT Debt, Non Current---15.0015.0015.0015.0015.0015.0015.0015.0014.00
Shareholder's Equity-3.4%174181191197201207215123127133139
  Retained Earnings-6.4%-156-146-134-124-118-110-100-97.17-92.00-84.56-78.47
  Additional Paid-In Capital1.0%329326324321319317315220219218217
Shares Outstanding0.8%32.0032.0032.0032.0031.0031.0031.0028.0027.0027.0027.00
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q1
Cashflow From Operations8.1%-28,583-31,111-20,930-25,034-23,020-19,915-29,082-17,530-6,409-2,3344,1312,399-12,796-12,672
  Share Based Compensation8.5%8,7688,0847,2076,0764,8673,4542,5041,9381,210798525291270264
Cashflow From Investing-121.3%-36,239-16,375-15,807-15,249-801-1,345-737-683-45073.00-9.00-12.00-368-364
Cashflow From Financing-6.1%-15,200-14,3321,17995,30095,61295,42194,725137,376136,898136,623137,19212.008.0012.00

MASS Income Statement

2023-06-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue$ 12,094$ 11,106$ 21,581$ 19,412
Cost of revenue6,3004,47211,4038,649
Gross profit5,7946,63410,17810,763
Operating expenses:    
Research and development5,5254,29310,9238,198
Selling, general and administrative11,20810,71023,21120,455
Total operating expenses16,73315,00334,13428,653
Loss from operations(10,939)(8,369)(23,956)(17,890)
Other income:    
Interest income1,6892932,706464
Interest expense (15)(551)(35)
Other expense, net(167)(8)(200)(53)
Total other income, net1,5222701,955376
Loss from operation before income taxes(9,417)(8,099)(22,001)(17,514)
Benefit for income taxes71 122 
Net loss$ (9,346)$ (8,099)$ (21,879)$ (17,514)
Net loss per share, basic$ (0.29)$ (0.26)$ (0.68)$ (0.56)
Net loss per share, diluted$ (0.29)$ (0.26)$ (0.68)$ (0.56)
Weighted average common shares outstanding, basic32,199,15631,413,43132,083,12231,312,559
Weighted average common shares outstanding, diluted32,199,15631,413,43132,083,12231,312,559
Product revenue    
Revenue$ 9,595$ 9,082$ 16,617$ 15,589
Cost of revenue4,8003,3048,5866,276
Service revenue    
Revenue2,3541,5264,5943,048
Cost of revenue1,4481,0572,7182,126
Contract revenue    
Revenue145498370775
Cost of revenue$ 52$ 111$ 99$ 247

MASS Balance Sheet

2023-06-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 132,996$ 188,422
Marketable securities19,6910
Accounts receivable, net of allowance for credit losses of $133 and $25 at June 30, 2023 and December 31, 202210,30810,033
Inventory14,13512,513
Prepaid expenses and other current assets3,9474,658
Total current assets181,077215,626
Operating lease, right-of-use assets7,1363,956
Property and equipment, net2,9403,083
Goodwill10,18510,050
Intangible assets, net8,1628,488
Other long-term assets1,3301,384
Total assets210,830242,587
Current liabilities:  
Accounts payable1,4861,397
Accrued expenses6,0348,847
Deferred revenue10,8147,514
Operating lease liabilities1,8601,468
Total current liabilities20,19419,226
Long-term debt 15,000
Operating lease liabilities, net of current portion4,9623,040
Deferred revenue, net of current portion8,47411,496
Deferred income taxes2,5852,671
Other long-term liabilities156555
Total liabilities36,37151,988
Commitments and contingencies
Stockholders' equity:  
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued or outstanding at June 30, 2023 and December 31, 2022, respectively
Common stock, $0.001 par value; 100,000,000 shares authorized; 32,326,861 shares and 31,859,847 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively3232
Additional paid-in capital329,361323,969
Accumulated other comprehensive income1,144798
Accumulated deficit(156,078)(134,200)
Total stockholders' equity174,459190,599
Total liabilities and stockholders' equity$ 210,830$ 242,587
Kevin J. Knopp
60
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.